AIMT - Aimmune Therapeutics Stock Trading

VEVEY, Switzerland , Sept. 14, 2020 /PRNewswire/ -- Société des Produits Nestlé S.A. ("Nestlé") announced that its wholly-owned subsidiary, SPN Merger Sub, Inc. ("Purchaser"), is commencing today a cash tender offer to purchase all of the outstanding shares of common s...

Shares of the peanut allergy drugmaker Aimmune Therapeutics (NASDAQ: AIMT) jumped by a jaw-dropping 159% during August, according to data provided by S&P Global Market Intelligence . The biopharma's shares took flight last month after the announcement of a $2.6 billion merger agreement...

A recent buyout offer for Aimmune (NASDAQ: AIMT) from its deep-pocketed collaboration partner, Nestle (OTC: NSRGY) , drove the biotech stock around 172% higher overnight. As is usually the case following one of these lucrative cash deals, lots of investors have started searching the healt...